The department of Clinical Trials is a good source of support for the pharmaceutical industry with its work in research, development and innovation that this industry promotes. To this end, it has incorporated the highest standards of quality in its work, offering a high degree of reliability and efficacy.
The department consists of three units: Phase II-IV Clinical Trials, Bioanalysis and Pharmacogenetics. Their work includes many of the stages involved in the Clinical Development of a drug. Their main fields of action include multicentre clinical trials with the support of the central laboratory. Other important areas are Pharmacogenomics, which studies genetic polymorphisms, microsatellites or in vitro models; and Bioanalysis/Pharmacokinetics, which performs quantitative analyses of drugs and their metabolites in biological matrices.
Cutting-edge technology is used, such as liquid chromatography coupled to mass spectrometry (LC-MS/MS), qualitative and quantitative real-time PCR, and all the technical and analytical equipment of the central laboratory.